Cited by 336Lipoproteins and Cardiovascular HealthCholesterol and Lipid MetabolismParaoxonase enzyme and polymorphisms

The DOI matches its Crossref record; 279 of the 282 references it cites were found in a registry or an index.

High-density lipoproteins: A consensus statement from the National Lipid Association

Toth, Peter P., Barter, Philip J., Rosenson, Robert S., Boden, William E., Chapman, M. John, Cuchel, Marina, D'Agostino, Ralph B., Davidson, Michael H., Davidson, W. Sean, Heinecke, Jay W., Karas, Richard H., Kontush, Anatol, Krauss, Ronald M., Miller, Michael, Rader, Daniel J.·2013·Journal of Clinical Lipidology

DOI 10.1016/j.jacl.2013.08.001

Open this paper in CoChat — free account

Abstract

For >4 decades it has been recognized that elevated serum levels of high-density lipoprotein cholesterol (HDL-C) are associated with reduced risk of cardiovascular disease (CVD) and its sequelae. Many prospective observational studies performed around the world have confirmed an inverse relationship between HDL-C and cardiovascular risk in people irrespective of sex, race, or ethnicity. Consequently, it was assumed that, by extension, raising HDL-C through lifestyle modification and pharmacologic intervention would reduce risk of CVD. Animal studies are consistent with this assumption. Lipid treatment guidelines around the world promoted the recognition of HDL-C as a therapeutic target, especially in high-risk patients. Some post hoc analyses from randomized controlled trials also suggest that raising HDL-C beneficially affects the risk of CVD. However, a number of recent randomized studies putatively designed to test the "HDL hypothesis" have failed to show benefit. The results of these trials have caused many clinicians to question whether HDL-C is a legitimate therapeutic target. In response to the many questions and uncertainties raised by the results of these trials, the National Lipid Association convened an expert panel to evaluate the current status of HDL-C as a therapeutic target; to review the current state of knowledge of HDL particle structure, composition, and function; and to identify the salient questions yet to be answered about the role of HDL in either preventing or contributing to atherosclerotic disease. The expert panel's conclusions and clinical recommendations are summarized herein. The panel concludes that, although low HDL-C identifies patients at elevated risk, and much investigation suggests that HDL may play a variety of antiatherogenic roles, HDL-C is not a therapeutic target at the present time. Risk stratified atherogenic lipoprotein burden (low-density lipoprotein cholesterol and non-HDL-C) should remain the primary and secondary targets of therapy in patients at risk, as described by established guidelines. The National Lipid Association emphasizes that rigorous research into the biology and clinical significance of low HDL-C should continue. The development of novel drugs designed to modulate the serum levels and functionality of HDL particles should also continue. On the basis of an enormous amount of basic scientific and clinical investigation, a considerable number of reasons support the need to continue to investigate the therapeutic effect of modulating HDL structure and function.

Integrity signals

Registry

Crossref · 10.1016/j.jacl.2013.08.001

Cites

279 of 279 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM
Havel, R. J., Eder, H. A., & Bragdon, J. H. (1955) · Journal of Clinical Investigation · doi:10.1172/jci103182 · Cited by 8,737
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491
Self-citation
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
Cholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550
Heart Disease and Stroke Statistics—2011 Update: A Report From the American Heart Association
Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Adams, R. J., Berry, J. D., Brown, T. M., Carnethon, M. R., Dai, S., de Simone, G., Ford, E. S., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182009701 · Cited by 6,149
High density lipoprotein as a protective factor against coronary heart disease
Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90874-9 · Cited by 5,059
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881 · cited 1×
“This possibility was further supported in the primary prevention Helsinki Heart Study (HHS) in which a 1% increase in HDL-C with gemfibrozil was associated with a 3% decrease in CVD events.(34) Another randomized controlled trial that tested the fibric acid gemfibrozil was the Veterans Affairs HDL Intervention Trial (…”
Result

Flagged first, then by citations

Show all 282 references

3 of the 282 references couldn’t be matched to a known paper.

Research works printed but not linked: 3

Voight, 2012, Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study, Lancet, 380, 572, 10.1016/S0140-6736(12)60312-2 · DOI · Paper page
Morse, 2001, Niacin plus simvastatin protect against atherosclerosis progression and clinical events in CAD patients with low HDL-C and diabetes mellitus or impaired fasting glucose, J Am Coll Cardiol, 37, 262A
Kannel, 1992, Efficacy of lipid profiles in prediction of coronary disease, Am Heart J, 124, 768, 10.1016/0002-8703(92)90288-7 · DOI

Sorted by citations

Items 201–300 of 336

Polycystic ovary syndrome influences the level of serum amyloid A and activity of phospholipid transfer protein in HDL2 and HDL3
Gidwani, S., Phelan, N., McGill, J. B., McGowan, A., O’Connor, A. S., Young, I. S., Gibney, J., & McEneny, J. (2014) · Human Reproduction · doi:10.1093/humrep/deu115 · Cited by 8
Plasma Nitration of High‐Density and Low‐Density Lipoproteins in Chronic Kidney Disease Patients Receiving Kidney Transplants
Bakillah, A., Tedla, F. M., Ayoub, I. M., John, D. G., Norin, A. J., Hussain, M. M., & Brown, C. D. (2015) · Mediators of Inflammation · doi:10.1155/2015/352356 · Cited by 8
Relationship of Riboflavin and Niacin with Cardiovascular Disease
Ahn, J. Y., Kim, I. S., & Lee, J.-S. (2019) · Korean Journal of Clinical Laboratory Science · doi:10.15324/kjcls.2019.51.4.484 · Cited by 8
HDL-C: Helpful, harmful, hopeful, or guilty by association
McLean, P., Mathew, D., Chandrasekhar, S. A., Guynn, N., Razavi, A. C., Quyyumi, A. A., Mehta, A., & Sperling, L. S. (2025) · Journal of clinical lipidology · doi:10.1016/j.jacl.2025.09.017 · Cited by 7
Comparison of the effects of 3 kinds of oils rich in omega-3 polyunsaturated fatty acids on glycolipid metabolism and lipoprotein subfractions
Liu, H., Wang, F., Xia, H., Pan, D., Yang, L., Wang, S., Zhao, F., & Sun, G. (2023) · Food Science and Human Wellness · doi:10.1016/j.fshw.2023.03.042 · Cited by 8
The pathophysiology of excess plasma-free cholesterol
Gillard, B. K., Rosales, C., Gotto, A. M., & Pownall, H. J. (2023) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000899 · Cited by 7
Consenso sobre tratamiento farmacológico de la dislipidemia aterogénica con terapia combinada estatina-fenofibrato
Aterogénica, P. E. D. E. V. E. D. G. D. T. S. D. (2016) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2015.12.001 · Cited by 7
A simple and precise method to detect sterol esterification activity of lecithin/cholesterol acyltransferase by high-performance liquid chromatography
Wang, Y., Wang, S., Zhang, L., Zeng, J., Yang, R., Li, H., Tang, Y., Chen, W., & Dong, J. (2018) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-017-0834-4 · Cited by 7
Improving lipid control following myocardial infarction
Ankam, J. V., Feldman, D. I., Blaha, M. J., & Martin, S. S. (2014) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000093 · Cited by 7
Sports and HDL-Quality Reflected By Serum Amyloid A and Surfactant Protein B
Sponder, M., Kopecky, C., Campean, I., Emich, M., Fritzer‐Szekeres, M., Litschauer, B., Graf, S., Säemann, M. D., & Strametz‐Juranek, J. (2017) · International Journal of Medical Sciences · doi:10.7150/ijms.20388 · Cited by 8
Urea-Assisted Reconstitution of Discoidal High-Density Lipoprotein
Fukuda, R., Saito, M., Shibukawa, S., Sumino, A., Nakano, M., & Murakami, T. (2020) · Biochemistry · doi:10.1021/acs.biochem.0c00075 · Cited by 7
Lipoprotein Particle Predictors of Arterial Stiffness after 17 Years of Follow Up: The Malmö Diet and Cancer Study
Hartz, J. C., Krauss, R. M., Gottsäter, M., Melander, O., Nilsson, P. M., & Mietus‐Snyder, M. (2020) · International Journal of Vascular Medicine · doi:10.1155/2020/4219180 · Cited by 7
Self-citation
The HDL paradox: what does it mean and how to manage low serum HDL cholesterol level?
Cybulska, B., & Kłosiewicz−Latoszek, L. (2014) · Kardiologia Polska · doi:10.5603/kp.a2014.0110 · Cited by 7
Effect of nonsurgical periodontal therapy on coronary artery disease or metabolic syndrome: a systematic review and meta-analysis
Su, Y., Cao, Y., Bing, X., Chen, C., Yan, H., Zhao, H., Wang, Y., Liu, S., Xie, Y., Li, C., et al. (2025) · Journal of Evidence Based Dental Practice · doi:10.1016/j.jebdp.2025.102136 · Cited by 6
Association of high-density lipoprotein cholesterol with all-cause and cause-specific mortality in the general population: insights from NHANES 1999–2018
Li, S., Fu, Z., & Zhang, W. (2025) · BMC Public Health · doi:10.1186/s12889-025-22251-z · Cited by 6
The associations of oxidized lipoprotein lipids with lipoprotein subclass particle concentrations and their lipid compositions. The Cardiovascular Risk in Young Finns Study
Kresanov, P., Mykkänen, J., Ahotupa, M. O., Ala‐Korpela, M., Juonala, M., Kaikkonen, J., Kähönen, M. A. P., Lehtimäki, T. J., Vasankari, T. J., Viikari, J. S. A., et al. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.10.020 · Cited by 5
An ApoA-I Mimic Peptide of 4F Promotes SDF-1α Expression in Endothelial Cells Through PI3K/Akt/ERK/HIF-1α Signaling Pathway
Lv, K., Kong, L., Yang, M., Zhang, L., Chu, S., Zhang, L., Yu, J., Zhong, G., Shi, Y., Wang, X., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.760908 · Cited by 6
Epidemiology: Disease Associations and Modulators of HDL-Related Biomarkers
Savolainen, M. J. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-09665-0_7 · Cited by 6
Emerging Therapeutic Approaches to Treat Dyslipidemia
Preiss, D., & Packard, C. J. (2014) · Current Cardiology Reports · doi:10.1007/s11886-014-0506-3 · Cited by 6
A rapid and precise method for measuring plasma apoE-rich HDL using polyethylene glycol and cation-exchange chromatography: a pilot study on the clinical significance of apoE-rich HDL measurements
Ikeda, T., Shinohata, R., Murakami, M., Hina, K., Kamikawa, S., Hirohata, S., Kusachi, S., Tamura, A., & Usui, S. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.12.016 · Cited by 6
Metabolic and morphometric changes in Indonesian cynomolgus monkeys (Macaca fascicularis) fed an atherogenic diet composed of locally sourced ingredients
Laila, S. R., Astuti, D. A., Suparto, I. H., Handharyani, E., & Sajuthi, D. (2018) · Veterinary World · doi:10.14202/vetworld.2018.1609-1617 · Cited by 6
Impact of variants in CETP and apo AI genes on serum HDL cholesterol levels in men and women from the Polish population
Włodarczyk, M., Wrzosek, M., Nowicka, G., & Jabłonowska-Lietz, B. (2016) · Archives of Medical Science · doi:10.5114/aoms.2016.60870 · Cited by 6
[HDL‐C/apoA‐I]: A multivessel cardiometabolic risk marker in women with T2DM
Hermans, M. P., Valensi, P. E., Ahn, S. A., & Rousseau, M. F. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2950 · Cited by 6
Correlation Between High-Density Lipoprotein and Monocyte Subsets in Patients with Stable Coronary Heart Disease
Jiang, S., Li, D., Li, J., & An, Y. (2015) · Medical Science Monitor · doi:10.12659/msm.894485 · Cited by 6
Retracted
Moderate/High-Intensity Exercise and Coenzyme Q10 Supplementation May Reduce Tumstatin and Improve the Lipid Dynamics and Body Mass in Rats
Yasul, Y., Akçınar, F., Çınar, V., Akbulut, T., Aydemir, İ., Yalçın, M. H., Avcu, E. Ç., Aydın, S., & Aydın, S. (2025) · Applied Sciences · doi:10.3390/app15052618 · Cited by 5
Emerging drugs for hyperlipidaemia: an update
Florentin, M., Kostapanos, M. S., Kei, A. A., & Elisaf, M. (2014) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2014.976553 · Cited by 5
Mathematical Modelling of Material Transfer to High-Density Lipoprotein (HDL) upon Triglyceride Lipolysis by Lipoprotein Lipase: Relevance to Cardioprotective Role of HDL
Schekatolina, S., Lahovska, V., Bekshaev, A. Y., Контуш, С. М., Goff, W. L., & Kontush, A. (2022) · Metabolites · doi:10.3390/metabo12070623 · Cited by 5
Self-citation
Streptococcal serum opacity factor promotes cholesterol ester metabolism and bile acid secretion in vitro and in vivo
Gillard, B. K., Rodriguez, P. J., Fields, D. W., Raya, J. L., Lagor, W. R., Rosales, C., Courtney, H. S., Gotto, A. M., & Pownall, H. J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2015.12.006 · Cited by 5
An update on trials of novel lipid-lowering drugs
Wierzbicki, A. S., Reynolds, T., & Viljoen, A. (2018) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000518 · Cited by 5
CODAP: um consenso multidisciplinar sobre a definição, diagnóstico e tratamento da dislipidemia aterogénica em Portugal
Silva, A. M. E., Aguíar, C., Duarte, J. S., Couto, L., Veríssimo, M. T., & da Silva, P. M. (2019) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2019.03.005 · Cited by 5
Phospholipid transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis is directly correlated with HDL-cholesterol levels and is not associated with cardiovascular risk
Ma, F., Darabi, M., Lhomme, M., Tubeuf, E., Canicio, A., Brerault, J., Medadje, N., Rached, F. H., Lebreton, S., Frisdal, É., et al. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.03.002 · Cited by 5
Self-citation
HDL-C/apoA-I Ratio Is Associated with the Severity of Coronary Artery Stenosis in Diabetic Patients with Acute Coronary Syndrome
Sun, L., Guo, M., Xu, C., Qiao, X., Hua, Y., Tuerhongjiang, G., Lou, B., Li, R., Bai, X., Zhou, J., et al. (2021) · Disease Markers · doi:10.1155/2021/6689056 · Cited by 5
Intakes of Milk and Soymilk and Cardiovascular Disease Risk in Korean Adults: A Study Based on the 2012~2016 Korea National Health and Nutrition Examination Survey
Ha, A. W., Kim, W. K., & Kim, S. H. (2023) · Journal of the Korean Society of Food Science and Nutrition · doi:10.3746/jkfn.2023.52.5.522 · Cited by 5
Relationship Between Time‐Varying Achieved High‐Density Lipoprotein Cholesterol and Risk of Coronary Events Depends on Haptoglobin Phenotype Within the ACCORD Lipid Study
Warren, R. A., Carew, A. S., Andreou, P., Levy, A. P., Sapp, J. L., Lache, O., Ginsberg, H. N., Rimm, E. B., Herman, C. R., Kirkland, S., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.030288 · Cited by 5
Analysis of the relationship of refractory gout between potential biomarkers and diet structure and lifestyle based on 1H-NMR
Liang, W., Chen, L., Cheng, X., Jianhong, P., & Ye, X. (2024) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-024-04540-2 · Cited by 5
Antiatherogenic Properties of High-Density Lipoprotein–Enriched MicroRNAs
Fernandez-Hernando, C. F. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303542 · Cited by 5
Exercise and the dipeptidyl‐peptidase IV inhibitor sitagliptin do not improve beta‐cell function and glucose homeostasis in long‐lasting type 1 diabetes—A randomised open‐label study
Seelig, E., Trinh, B., Hanssen, H., Schmidt‐Trucksäss, A., Ellingsgaard, H., Christ‐Crain, M., & Donath, M. Y. (2019) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.75 · Cited by 4
Atherogenesis and Inflammation
Shishikura, D., Octavia, Y., Hayat, U., Thondapu, V., & Barlis, P. (2022) · Interventional Cardiology · doi:10.1002/9781119697367.ch1 · Cited by 6
Short-term lifestyle intervention program through daily walking improves circulatory low HDL level in rural Bangladeshi women
Jesmin, S., Sohael, F., Rahman, M. A., Maqbool, A., Islam, M. M., Shima, T., Shimojo, N., Moroi, M., Yamaguchi, N., Watanabe, K., et al. (2020) · The Journal of Physical Fitness and Sports Medicine · doi:10.7600/jpfsm.9.181 · Cited by 4
JCL Roundtable: HDL in the primary care setting
Brown, W. V., Ansell, B. J., Mackey, R. H., & Toth, P. P. (2014) · Journal of clinical lipidology · doi:10.1016/j.jacl.2014.05.009 · Cited by 4
Self-citation
High-density lipoproteins
Sparks, C. E., Corsetti, J. P., & Sparks, J. D. (2014) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000079 · Cited by 4
Sex and Racial Differences in High-Density Lipoprotein Levels in Acute Coronary Syndromes
Ozaki, A., Bravo‐Jaimes, K., Smotherman, C. R., Kraemer, D. F., Samura, A., & Velarde, G. (2021) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2021.04.013 · Cited by 4
ABCA1 and apoA-I dependent 12-hydroxyeicosatetraenoic acid efflux regulates macrophage inflammatory signalingPreprint
Harsch, B. A., Borkowski, K., Walker, R. E., Pedersen, T. L., Newman, J. W. I., & Shearer, G. C. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.11.603001 · Cited by 4
Skeletal Muscle Mass is Associated with HDL Cholesterol Levels and the Ratio of LDL to HDL Cholesterol in Young Men: A Pilot Study
(2022) · Journal of Men's Health · doi:10.31083/j.jomh1808171 · Cited by 3
Association between metabolic health indicators and cardiorespiratory fitness in urban young and middle-aged population: a retrospective cross-sectional study
Wang, C., Yang, N., Zhang, Q., Li, Y., Zhang, L., Liu, Z., Zhao, R., Qi, J., Xiang, A., Fu, Y., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1489152 · Cited by 4
The prospective association between high-density lipoprotein (HDL) cholesterol and risk of incident fractures in the general population
Sutton, R., Rogmark, C., Fedorowski, A., Hamrefors, V., & Johansson, M. (2025) · Osteoporosis International · doi:10.1007/s00198-025-07732-6 · Cited by 3
Effects of probiotics on blood lipids, glucose and pressure in patients with coronary heart disease: a systematic review and meta-analysis
Zhong, Y., Yang, X., Kong, W., Shi, Y., & JIAN, W. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1707408 · Cited by 3
The Application of Proteomic Techniques in the Study of HDL Particle Characterization and Biomarker Discovery
Burillo, E., Jorge, I., Martínez-López, D., Camafeita, E., Vázquez, J., & Martı́n-Ventura, J. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-812513-7.00011-2 · Cited by 3
Low HDL Cholesterol is Associated with Reduced Bleeding Risk in Patients who Underwent PCI: Findings from the PRACTICE Study
Zheng, Y., Wu, T., Hou, X., Yang, Y., Yang, H.-T., Pan, Y., Xiu, W., Ma, X., Ma, Y., Yang, X.-L., et al. (2023) · Thrombosis and Haemostasis · doi:10.1055/a-2104-1693 · Cited by 3
Cardiovascular Disease Epidemiology and Risk Factors: General Concepts
Toth, P. P. (2021) · Contemporary cardiology · doi:10.1007/978-3-030-62632-7_1 · Cited by 3
Self-citation
Study on influencing factors of anthracycline-induced subclinical cardiotoxicity in DLBCL patients administered (R)-CHOP
Dong, Q., Ou, W., Wang, M., Jiang, T., Weng, Y., Zhou, X., & Tang, X. (2022) · BMC Cancer · doi:10.1186/s12885-022-10085-6 · Cited by 3
Multilayer analysis of ethnically diverse blood and urine biomarkers for breast cancer risk and prognosis
Feng, J. F., Qi, X., Chen, C., Li, B., Wang, M., Xie, X., Yang, K., Liu, X., Chen, R. M., Guo, T., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-90447-9 · Cited by 4
The High Density Lipoprotein Cholesterol Hypothesis Revisited
Meiliana, A., Dewi, N. M., & Wijaya, A. (2018) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v10i2.465 · Cited by 2
Lipoprotein Subfractions in Patients with Acute Coronary Syndromes: Should we Reach Beyond LDL-C?
Toth, P. (2019) · Current Vascular Pharmacology · doi:10.2174/1570161116999180613120902 · Cited by 2
Self-citation
Erratum: The association between the DNAH11 rs10248618 SNP and serum lipid traits, the risk of coronary artery disease, and ischemic stroke.
Zhou, Y.-G., Yin, R., Wu, J., Zhang, Q.-H., Chen, W., & Cao, X. (2018) · Europe PMC (PubMed Central) · Cited by 3
Associations of high-density lipoprotein cholesterol, particles and subspecies with the risk of hypertension: findings from the PREVEND prospective study
Kunutsor, S. K., Connelly, M. A., Shah, A. H., Bakker, S. J. L., & Dullaart, R. P. F. (2025) · Journal of Hypertension · doi:10.1097/hjh.0000000000004014 · Cited by 2
Low plasma apolipoprotein E-rich high-density lipoprotein levels in patients with metabolic syndrome
Shinohata, R., Shiga, Y., Miura, S.-I., Hirohata, S., Shibakura, M., Ueno-Iio, T., Watanabe, S., Arao, Y., & Usui, S. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.08.020 · Cited by 2
Occupational Exposure to Air Pollutants Among Professional Motorcyclists in Brazil Results in Higher Health Risk and Changing in Biochemical and Cardiovascular Parameters
Carvalho, R. B., Marmett, B., Amantéa, S. L., & Rhoden, C. R. (2022) · Water Air & Soil Pollution · doi:10.1007/s11270-022-05794-4 · Cited by 2
Combined impacts of low apolipoprotein A-I levels and reduced renal function on long-term prognosis in patients with coronary artery disease undergoing percutaneous coronary intervention
Fukase, T., Dohi, T., Nishio, R., Takeuchi, M., Takahashi, N., Chikata, Y., Endo, H., Doi, S., Nishiyama, H., Okai, I., et al. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2022.09.020 · Cited by 2
Associations of an HDL apolipoproteomic index with cardiometabolic risk factors before and after exercise training in the HERITAGE Family Study
Maravi, J. S. M., Leszczynski, E. C., Schwartz, C. S., Dev, P. K., Barber, J. L., Reasons, R. J., Pearce, R. W., McPhaul, M. J., Konrad, R. J., Robbins, J., et al. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.117587 · Cited by 2
Ethnicity and coronary artery disease: the role of high-density lipoprotein – a change in paradigm
Bravo‐Jaimes, K., & Velarde, G. (2015) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2015.1065178 · Cited by 2
Revising the high-density lipoprotein targeting strategies – Insights from human and preclinical studies
Nesan, D., & Ng, D. S. (2014) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2014.937523 · Cited by 2
A robust all-atom model for LCAT generated by homology modeling
Segrest, J. P., Jones, M. K., Catte, A., & Thirumuruganandham, S. P. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m056382 · Cited by 2
Dyslipidemia aterogenna w codziennej praktyce — interdyscyplinarny konsensus polskich ekspertów
Szymański, F. M., Filipiak, K. J., Wożakowska−Kapłon, B., Szaflik, J. P., Dzida, G. J., Kurkowska‐Jastrzębska, I., Narkiewicz, K., Łazicka-Gałecka, M., Gil, R. J., & Gumprecht, J. (2017) · Folia Cardiologica · doi:10.5603/fc.a2016.0106 · Cited by 2
What do we know about lipoprotein(a)?
Cybulska, B., & Kłosiewicz−Latoszek, L. (2015) · Kardiologia Polska · doi:10.5603/kp.a2014.0244 · Cited by 2
Carotid Artery Intima–Media Thickness Predicts Major Cardiovascular Events During 7-Year Follow-Up in 64-Year-Old Women Irrespective of Other Glucometabolic Factors
Schmidt, C. B., & Bergström, G. M. L. (2016) · Angiology · doi:10.1177/0003319716672526 · Cited by 2
CODAP: A multidisciplinary consensus among Portuguese experts on the definition, detection and management of atherogenic dyslipidemia
Silva, A. M. E., Aguíar, C., Duarte, J. S., Couto, L., Veríssimo, M. T., & da Silva, P. M. (2019) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2019.03.010 · Cited by 2
Rare variants in previously identified linkage regions associated with carotid plaque in Dominican Republic families
Dueker, N., Beecham, A. H., Wang, L., Dong, C., Sacco, R. L., Blanton, S. H., & Rundek, T. (2022) · PLoS ONE · doi:10.1371/journal.pone.0250799 · Cited by 2
Deteriorative Effect of a Combination of Hypertriglyceridemia and Low High-Density Lipoprotein Cholesterolemia on Target Lesion Revascularization after Everolimus-Eluting Stent Implantation
Kimura, M., Takeda, T., Tsujino, Y., Matsumoto, Y., Yamaji, M., Sakaguchi, T., Maeda, K., Mabuchi, H., & Murakami, T. (2023) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.64010 · Cited by 2
Discovery of High-Density Lipoprotein Gene Targets from Classical Genetics to Genome-Wide Association Studies
Freeman, L. A., & Remaley, A. T. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-799961-6.00006-8 · Cited by 2
Lower than average HDL cholesterol efflux capacity in Lithuanian population
Kutkienė, S., Petrulionienė, Ž., Karčiauskaitė, D., Laucevičius, A., Matuzevičienė, G., Staigytė, J., Saulyte, A., Gargalskaite, U., Skiauterytė, E., & Kovaitė, M. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1124-2 · Cited by 2
Pathogenesis of atherosclerosis: lipid metabolism
Wiklund, O., & Borén, J. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780198755777.003.0011 · Cited by 2
Plant- and Animal-Derived Omega-3 Polyunsaturated Fatty Acids Improve Glucose and Lipid Metabolism in Patients with Type 2 Diabetes and DyslipidemiaPreprint
Liu, H., Wang, F., Li, Y., Xia, H., Pan, D., Yang, L., Wang, S., & Sun, G. (2020) · Preprints.org · doi:10.20944/preprints202010.0563.v1 · Cited by 1
Evaluation of lipid profile in systemic lupus erythematosus and relation with interleukin-10
Verma, S., Nanda, R., Shah, S., Meher, J., Rathore, V., Patel, S., & Mohapatra, E. (2024) · Journal of Laboratory Physicians · doi:10.25259/jlp-2023-8-13-(1909 · Cited by 1
High-Density Lipoproteins from Coronary Artery Disease and Aortic Valve Stenosis Patients Differentially Regulate Gene Expression in a Model of Cardiac Adipocytes
Luna‐Luna, M., Páez, A., Massó, F., López‐Marure, R., Zozaya-García, J. M., Vargas‐Castillo, A., Gómez-Pineda, D., Tovar, A. R., Magaña, J. J., Fragoso, J. M., et al. (2025) · Cells · doi:10.3390/cells14030205 · Cited by 1
High‐Density Lipoprotein Cholesterol Levels and the Risk of Acromegaly: A Nationwide Cohort Study
Roh, E., Heo, J. H., Jung, H. N., Han, K., Kang, J. G., Lee, S. J., & Ihm, S. (2025) · Clinical Endocrinology · doi:10.1111/cen.15264 · Cited by 2
High-density lipoprotein cholesterol, particles and subspecies and the risk of chronic kidney disease: The PREVEND prospective study
Kunutsor, S. K., Connelly, M. A., Bakker, S. J. L., & Dullaart, R. P. F. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02668-6 · Cited by 1
Association of the HDL lipidome with HDL traits before and after exercise training: HERITAGE family study
Dev, P. K., Leszczynski, E. C., Schwartz, C. S., Barber, J. L., Ayala, E. J., Wang, X., Fairman, C. M., Ghosh, S., Gerszten, R. E., Olivier, M., et al. (2025) · Metabolomics · doi:10.1007/s11306-025-02330-3 · Cited by 1
Association of HDL subclass components with all-cause and cardiovascular mortality: a prospective cohort study based on the ChinaHEART project
Liu, X., Lin, S., Zhang, H., Zhang, X., Wu, M. C., Chen, B., Yang, Y., Cui, J., Xu, W., Song, L., et al. (2026) · Lipids in Health and Disease · doi:10.1186/s12944-026-02874-w · Cited by 1
A narrative review of impacts of apolipoproteins on atherosclerotic coronary plaques
Fukase, T., & Dohi, T. (2026) · npj Cardiovascular Health · doi:10.1038/s44325-026-00104-x · Cited by 2
Serum non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and the risk of sudden cardiac death: findings from a prospective cohort study
Laukkanen, J. A., Kurl, S., Ravandi, A., Kauhanen, J., & Kunutsor, S. K. (2026) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2026.104706 · Cited by 1
Association of high density lipoprotein levels with advancing age in type 2 diabetes patients in Tertiary Hospital.
Khan, S. A., & Imtiaz, I. (2019) · The Professional Medical Journal · doi:10.29309/tpmj/2019.26.09.3268 · Cited by 1
Preβ1-High-Density Lipoprotein in Cardiovascular Diseases
Chen, Y., & Dong, J. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-6082-8_12 · Cited by 1
Electricity use is associated with residents’ vital data and lifestyles: observational study using an IT health support system in Japan
Yasukawa, K., Ishihara, Y., Hirayama, F., Nakanishi, M., Utsumi, H., & Koyama, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-74359-4 · Cited by 1
Association between changes in high-density lipoprotein cholesterol and risk of cardiovascular disease
Wang, Y., Yan, T., Yang, Y., Li, L., Zhang, Z., Cao, X., Xia, Y., Shen, Y., Liu, K., Xu, L., et al. (2024) · Journal of clinical lipidology · doi:10.1016/j.jacl.2024.09.001 · Cited by 1
Cardiovascular Risk Assessment in the Immediate Postoperative Period of Bariatric Surgery
Bratti, L. D. O. S., Martins, A. C., Nunes, B. F., Moura, E. Q. D. A., de Moraes, A. C. R., & Filippin-Monteiro, F. B. (2025) · Obesities · doi:10.3390/obesities5010005 · Cited by 1
The impact of in utero tobacco exposure on smoking behaviors, cardiovascular disease risk and all-cause mortality in adulthood: A UK Biobank study
Zheng, Y., Xiong, X., Bao, J., Liu, J., Wang, J., Zou, F., Chen, Z., Guo, Y., Wang, Q., Qiu, Y., et al. (2025) · Current Research in Toxicology · doi:10.1016/j.crtox.2025.100226 · Cited by 1
Association of Age-Related Macular Degeneration with Cholelithiasis
Zhang, K. R., Nair, R. M., Chen, Y., Jin, F., Dunaief, J. L., & VanderBeek, B. L. (2025) · Ophthalmology Science · doi:10.1016/j.xops.2025.100771 · Cited by 1
Lipid Management in Human Immunodeficiency Virus
Myerson, M. L. (2015) · Cardiology Clinics · doi:10.1016/j.ccl.2015.01.003 · Cited by 1
Therapies Targeting HDLc Levels and HDL Function
Vitali, C., & Cuchel, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-812513-7.00012-4 · Cited by 1
Self-citation
Effect of lockdown due to COVID-19 pandemic on lipid profile of Indian male population
Tripathy, S. K., & Ray, S. (2021) · International Journal of Scientific Reports · doi:10.18203/issn.2454-2156.intjscirep20213258 · Cited by 1
Sub-chronic cadmium exposure in drinking water dysregulates lipid and glucose metabolisms in ApoE (-/-) mice: Molecular insights into the etiology of atherosclerosisPreprint
Okpara, E. S., Wan, Y., Huang, H., Song, J., Zhu, W., Yang, G., & Professor Xingfen, Y. A. N. G. (2021) · Research Square · doi:10.21203/rs.3.rs-619148/v1 · Cited by 1
Investigation of total HDL and HDL subclass kinetics using stable isotope techniques in healthy subjects
Wang, K. (2015) · Surrey Research Insight Open Access (The University of Surrey)
From the Editor: The importance of children
Brown, W. V. (2013) · Journal of clinical lipidology · doi:10.1016/j.jacl.2013.09.001
High-density lipoprotein and endothelial function in patients with myocardial infarction: Pieces in a puzzle
Martin, S. S., Joshi, P. H., & Blaha, M. J. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.10.026
Role of the inflammasome pathway in atherosclerosis
Rajamäki, K. (2015) · Työväentutkimus Vuosikirja
Oxidized LDL lipids as a risk factor for atherosclerosis
Linna, M. S. (2014) · UTUPub (University of Turku)
Pravastatin: A First Generation HMG CoA Reductase Inhibitor ☆
Reagan, J. W. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.97874-7
Atheroinflammatory Properties of LDL and HDL Particles Modified by Human Mast Cell Neutral Proteases
Maaninka, K. (2018) · Työväentutkimus Vuosikirja
Impacto da incorporação de ômega 3 na funcionalidade da lipoproteína de alta densidade: ensaio clínico aleatorizado, paralelo e controlado
Cartolano, F. D. C. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.6.2019.tde-10102018-080400

Authors: Toth, P. P., Barter, P. J., Rosenson, R. S., Boden, W. E., Chapman, M. J., Cuchel, M., D'Agostino, R. B., Davidson, M. H., Davidson, W. S., Heinecke, J. W., Karas, R. H., Kontush, A., Krauss, R. M., Miller, M., & Rader, D. J.
Affiliations: CGH Medical Center (US)
The Heart Research Institute (AU)
Icahn School of Medicine at Mount Sinai (US)
Albany Medical College (US)
Inserm (FR)
University of Pennsylvania (US)
University of Chicago (US)
University of Cincinnati (US)
University of Washington (US)
Tufts University (US)
University of California, San Francisco (US)
University of Maryland, Baltimore (US)
Corresponding author: Toth, Peter P.
ORCID: Toth, Peter P.
Rosenson, Robert S.
Boden, William E.
Chapman, M. John
Cuchel, Marina
Davidson, Michael H.
Davidson, W. Sean
Heinecke, Jay W.
Karas, Richard H.
Kontush, Anatol
Krauss, Ronald M.
Miller, Michael
Rader, Daniel J.
Venue: Journal of Clinical Lipidology
Publisher: Elsevier BV
Published: 2013-09
Volume: 7
Issue: 5
Pages: 484-525
ISSN: 1876-4789 (ISSN-L)
1933-2874
DOI: 10.1016/j.jacl.2013.08.001
OpenAlex: W2106601510
Cited by: 336
References: 282
Citations by year: 2026: 6 · 2025: 21 · 2024: 10 · 2023: 21 · 2022: 34 · 2021: 24 · 2020: 38 · 2019: 25 · 2018: 28 · 2017: 26 · 2016: 19 · 2015: 41 · 2014: 41 · 2013: 2
FWCI: 33.82
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Journal of clinical lipidology (publishedVersion)
PubMed (publishedVersion)
Funders: National Heart, Lung, and Blood Institute (R01HL112625)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
Keywords: HDL cholesterol, cardiovascular risk, atherosclerosis, LDL cholesterol, non-HDL cholesterol, risk stratification
MeSH terms: Animals, Cardiovascular Diseases, Humans, Lipoproteins, HDL, Risk Factors, Societies, Scientific, Consensus, Molecular Targeted Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

High-density lipoproteins: A consensus statement from the National Lipid Association

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks